An experimental drug modestly slowed the worsening of Alzheimer's, researchers say, but it's unclear how much difference it might really make.
An experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening, researchers reported Tuesday, but it remains unclear how much difference that might make in people's lives.
People are also reading… Those given lecanemab declined more slowly — a difference of not quite half a point on that scale, concluded the research team led by Dr. Christopher van Dyck at Yale University. But Dr. Ron Petersen, an Alzheimer's expert at the Mayo Clinic, said the drug's effect was"a modest one but I think it's clinically meaningful" — because even a few months' delay in progression could give someone a little more time when they're functioning independently.
Listen now and subscribe: Apple Podcasts | Google Podcasts | Spotify | Stitcher | RSS Feed | Omny Studio Amyloid-targeting drugs can cause side effects that include swelling and bleeding in the brain, and lecanemab did as well. One type of this swelling was seen in about 13% of recipients. Eisai said most were mild or asymptomatic.
The Food and Drug Administration is considering approving lecanemab under its fast-track program, with a decision expected in early January. If approved, it would be the second anti-amyloid drug on the market. Food and Cooking Top three taxpayer concerns for 2022 If you’re expecting a tax refund this year, you may be concerned about a few things. These are the top three concerns taxpayers have right now…
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Promising New Cancer Therapy Developed by Albert Einstein College of MedicineImmune checkpoints are a normal part of the immune system. Their function is to prevent an immune response from being so powerful that it destroys healthy cells in the body. Immunotherapy drugs called immune checkpoint inhibitors, such as Keytruda and Opdivo, work by unleashing the immune system’s T
Read more »
Promising Alzheimer’s drug needs to be studied for safety, researchers sayAn experimental Alzheimer’s drug moderately slowed the effects of the disease but was linked to patient safety risks that warrant longer clinical trials, according to a study published late Tuesday.
Read more »
Promising drug slows Alzheimer's, but can it make a real difference?An experimental drug modestly slowed the worsening of Alzheimer's, researchers say, but it's unclear how much difference it might really make.
Read more »
Kensington made a new wireless version of its SlimBlade trackball mouseKensington is promising up to four months of battery life.
Read more »
New Research Indicates That Mars Was Capable of Supporting LifeEarly Mars might have been a warm version of modern Titan and at least as promising, if not more promising, as a location for the origin of life. A new study reveals that Mars was born wet, with a dense atmosphere allowing warm-to-hot oceans for millions of years. This discovery was recently publ
Read more »
Early research suggests promising use of AI to predict risk of heart attack or stroke using a single chest X-ray | CNNEarly research suggests a promising use of artificial intelligence to predict the 10-year risk of death from a heart attack or stroke from a single chest X-ray.
Read more »